Systems and methods for delivery of therapeutic gas

US11529479B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11529479-B2
Application numberUS-202016748319-A
CountryUS
Kind codeB2
Filing dateJan 21, 2020
Priority dateMay 9, 2014
Publication dateDec 20, 2022
Grant dateDec 20, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system. The therapeutic gas delivery system controller of the system includes a processor that executes an algorithm to calculate the run-time-to-empty from the data received from the gas pressure sensor, temperature sensor, flow controller and flow sensor, and directs the result to the display.

First claim

Opening claim text (preview).

What is claimed is: 1. An electronically controlled gas blending device, comprising: a flow control channel operable to receive a therapeutic gas flow, the flow control channel in fluid communication with a secondary shut off valve, a secondary flow control valve, a secondary delivery flow sensor, and a secondary confirmatory flow sensor; a flow regulating valve at a blending junction, the flow regulating valve in fluid communication with the flow control channel and operable to deliver the therapeutic gas to a primary outlet, a low pressure outlet, and an injector module; a low pressure confirmatory flow sensor in fluid communication with the primary outlet; a low pressure delivery flow sensor in fluid communication with the low pressure confirmatory flow sensor; and a secondary delivery subsystem controller in electronic communication with the secondary shut off valve, the secondary flow control valve, the secondary delivery flow sensor, the secondary confirmatory flow sensor, the flow regulating valve, the low pressure confirmatory flow sensor, and the low pressure delivery flow sensor. 2. The electronically controlled gas blending device of claim 1 , further comprising a pressure sensor in fluid communication with the low pressure confirmatory flow sensor, the low pressure delivery flow sensor, and/or the low pressure outlet. 3. The electronically controlled gas blending device of claim 1 , further comprising an overpressure valve in fluid communication with the primary outlet, wherein the overpressure valve is configured to open at a predetermined pressure to avoid pressure surges. 4. The electronically controlled gas blending device of claim 1 , wherein the low pressure outlet is operable for connection to a manual ventilation device. 5. The electronically controlled gas blending device of claim 1 , wherein the primary outlet is connected to low pressure inlet port 165 operable for connection to a low pressure air/O 2 supply. 6. The electronically controlled gas blending device of claim 1 , wherein the flow control channel is in fluid communication with one or more therapeutic gas supply subsystems. 7. The electronically controlled gas blending device of claim 1 , wherein the secondary delivery subsystem controller is configured to: receive a set dose of therapeutic gas from a primary gas delivery subsystem and a flow value from the secondary delivery flow sensor and/or the secondary confirmatory flow sensor; calculate a flow rate of the therapeutic gas through the low pressure delivery flow sensor or the low pressure confirmatory flow sensor to provide a dose of the therapeutic gas exiting the blending junction; and compare the dose of the therapeutic gas exiting the blending junction to the set dose. 8. The electronically controlled gas blending device of claim 1 , wherein the secondary delivery subsystem controller is configured to generate an alarm signal if the flow values from the low pressure confirmatory flow sensor the low pressure delivery flow sensor are not about the same. 9. The electronically controlled gas blending device of claim 1 , wherein the pressure sensor communicates pressure values to the secondary delivery subsystem controller, and the secondary delivery subsystem controller is configured to detect pressure fluctuations in the pressure sensor.

Assignees

Inventors

Classifications

  • Detection of the presence or absence of a tube, a connector or a container in an apparatus · CPC title

  • involving measurement of pressure · CPC title

  • Measuring a parameter of the content of the delivered gas · CPC title

  • with O2 features or with parameter measurement · CPC title

  • used for inhalation control · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11529479B2 cover?
Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned…
Who is the assignee on this patent?
Mallinckrodt Pharmaceuticals Ireland Ltd
What technology area does this patent fall under?
Primary CPC classification A61M16/0051. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).